Abstract: A record player capable of playing phonographic records that may be played in a scratch style by a user. The record player includes a tonearm that is rotatably supported at or near an end of the tonearm by a structure having both horizontally and vertically fastening points to the tonearm. The fastening points are configured to receive a user activated tension adjustment element. A user may advance or retreat the tension adjustment element to selectably control the positioning, or relative tension in the tonearm such that any record skipping due to undesirable tonearm pressure is controlled, or to achieve a specific sound.

Abstract: A record player capable of playing phonographic records that may be played in a scratch style by a user. The record player includes a tonearm that is rotatably supported at or near an end of the tonearm by a structure having both horizontally and vertically fastening points to the tonearm. The fastening points are configured to receive a user activated tension adjustment element. A user may advance or retreat the tension adjustment element to selectably control the positioning, or relative tension in the tonearm such that any record skipping due to undesirable tonearm pressure is controlled, or to achieve a specific sound.

Abstract: Compounds of the formula provide pharmacological agents which are potent agonists of Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the treatment of conditions mediated by the PPAR receptor activity in mammals. Such conditions include dyslipidemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity, inflammation, arthritis, cancer, Alzheimer's disease, skin disorders, respiratory diseases, ophthalmic disorders, inflammatory bowel diseases, ulcerative colitis and Crohn's disease. The compounds of the present invention are particularly useful in mammals as hypoglycemic agents for the treatment and prevention of conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X.